Infection control in the intensive care unit

Surgical Clinics of North America

Volumn 94, Issue 6, 2014, Pages 1175-1194

  Osman, Mohamed F ^a   Askari, Reza ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Health care personnel; ICU acquired infections; Infection control; Intensive care unit

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; GLUCOSE; INSULIN;

ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; CATHETER INFECTION; CLOSTRIDIUM DIFFICILE INFECTION; COST BENEFIT ANALYSIS; ENTERIC FEEDING; EVIDENCE BASED PRACTICE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HAND WASHING; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INSULIN RESISTANCE; INTENSIVE CARE; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NUTRITIONAL STATUS; POSTURAL DRAINAGE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; REVIEW; RISK FACTOR; SCIENTIST; SEPTIC SHOCK; STAFF TRAINING; SUPINE POSITION; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; CATHETER-RELATED INFECTIONS; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; PEPTOCLOSTRIDIUM DIFFICILE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROCEDURES; URINARY TRACT INFECTIONS;

CATHETER-RELATED INFECTIONS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 84923647269     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2014.08.011     Document Type: Review

References (192)

1. Society of Critical Care Medicine: evaluating ICU care in your community. 2008. Available at: Accessed on January 28, 2014. http://www.myicu.org/Support_Brochures/Pages/EvaluatingICUinYourCommunity.aspx.
2. Society of Critical Care Medicine Critical care units: a descriptive analysis 2005, Society of Critical Care Medicine, Des Plaines (IL). 1st edition.
3. Fridkin S.K., Welbel S.F., Weinstein R.A. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997, 11:479.
4. Vincent J.L., Rello J., Marshall J., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323.
5. Kaye K.S., Marchaim D., Smialowicz C., et al. Suction regulators: a potential vector for hospital-acquired pathogens. Infect Control Hosp Epidemiol 2010, 31:772.
6. Dempsey D.T., Mullen J.L., Buzby G.P. The link between nutritional status and clinical outcome: can nutritional intervention modify it?. Am J Clin Nutr 1988, 47:352-356.
7. Bistrian B.R., Blackburn G.L., Scrimshaw N.S., et al. Cellular immunited in semistarved states in hospitalized adults. Am J Clin Nutr 1975, 28:1148-1155.
8. Cunningham-Rundles S. Analytical methods for evaluation of immune response in nutrient intervention. Nutr Rev 1998, 56(1 Pt 2):S27-S37.
9. Scrimshaw N.S. Historical concepts of interactions, synergism and antagonism between nutrition and infection. JNutr 2003, 133(1):316S-321S.
10. Keusch G.T. The history of nutrition: malnutrition, infection and immunity. JNutr 2003, 133(1):336S-340S.
11. Kaya E., Yetim I., Dervisoglu A., et al. Risk factors for and effect of a one-year surveillance program on a surgical site infection at a university hospital in Turkey. Surg Infect (Larchmt) 2006, 7(6):519-526.
12. Rapp-Kesek D., Ståhle E., Karlsson T. Body mass index and albumin in the preoperative evaluation of cardiac surgery patients. Clin Nutr 2004, 23:1398-1404.
13. Rubinson L., Diette G.B., Song X., et al. Low caloric intake is associated with nosocomial bloodstream infections in patients in the medial intensive care unit. Crit Care Med 2004, 32(2):350-357.
14. Simpson F., Doig G.S. Parenteral vs enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle. Intensive Care Med 2005, 31(1):12-23.
15. Bonten M.J., Kollef M.H., Hall J.B. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004, 38:1141-1149.
16. Vasken A., Krayem H., DiGiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest 2006, 129:960-967.
17. Drakulovic M.B., Torres A., Bauer T.T., et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet 1999, 354:1851-1858.
18. Gramlich L., Kichian K., Pinilla J., et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition 2004, 20(10):843-848.
19. Radrizzani D., Bertolini G., Facchini R., et al. Early enteral immunonutrition vs. parenteral nutrition in critically ill patients without severe sepsis: a randomized clinical trial. Intensive Care Med 2006, 32:1191-1198.
20. Mizock B.A. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995, 98:75-84.
21. McCowen K.C., Malhotra A., Bistrian B.R. Stress-induced hyperglycemia. Crit Care Clin 2001, 17:107-124.
22. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778.
23. Cely C.M., Arora P., Quartin A.A., et al. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 2004, 126:879-887.
24. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. NEngl J Med 2001, 345:1359-1367.
25. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003, 31:359-366.
26. Latham R., Lancaster A.D., Covington J.F., et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001, 22(10):607-612.
27. Bochicchio G.V., Sung J., Joshi M., et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. JTrauma 2005, 58(5):921-924.
28. Grey N.J., Perdrizet G.A. Reduction of nosocomial infections in the surgical intensive- care unit by strict glycemic control. Endocr Pract 2004, 10(Suppl 2):46-52.
29. Jain M., Miller L., Belt D., et al. Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change. Qual Saf Health Care 2006, 15(4):235-239.
30. Berriel-Cass D., Adkins F.W., Jones P., et al. Eliminating nosocomial infections at Ascension health. Jt Comm J Qual Patient Saf 2006, 32(11):612-620.
31. Harrigan S., Hurst D., Lee C., et al. Developing and implementing quality initiatives in the ICU: strategies and outcomes. Crit Care Nurs Clin North Am 2006, 18(4):469-479.
32. Misset B., Timsit J.F., Dumay M.F., et al. Acontinuous quality-improvement program reduces nosocomial infection rates in the ICU. Intensive Care Med 2004, 30(3):395-400.
33. Apisarnthanarak A., Pinitchai U., Thongphubeth K., et al. Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis 2007, 45(6):704-711.
34. Zack J.E., Garrison T., Trovillion E., et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002, 30(11):2407-2412.
35. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter- related bloodstream infections in the ICU. NEngl J Med 2006, 355(26):2725-2732.
36. Lobo R.D., Levin A.S., Gomes L.M., et al. Impact of an educational program and policy changes on decreasing catheter-associated bloodstream infections in a medical intensive care unit in Brazil. Am J Infect Control 2005, 33(2):83-87.
37. Hugonnet S., Chevrolet J., Pittet D. The effect of workload on infection risk in critically ill patients. Crit Care Med 2007, 35(1):76-81.
38. Hugonnet S., Uc kay I., Pittet D. Staffing level: a determinant of late-onset ventilator- associated pneumonia. Crit Care 2007, 11(4):R80.
39. Fridkin S.K., Pear S.M., Williamson T.H., et al. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996, 17(3):150-158.
40. Pittet D., Dharan S., Touveneau S., et al. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999, 159(8):821-826.
41. Markogiannakis A., Fildisis G., Tsiplakou S., et al. Cross-transmission of multidrugresistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect Control Hosp Epidemiol 2008, 29(5):410-417.
42. Ojajärvi J. Effectiveness of hand washing and disinfection methods in removing transient bacteria after patient nursing. JHyg (Lond) 1980, 85(2):193-203.
43. Oelberg D.G., Joyner S.E., Jiang X., et al. Detection of pathogen transmission in neonatal nurseries using DNA markers as surrogate indicators. Pediatrics 2000, 105(2):311-315.
44. Bures S., Fishbain J.T., Uyehara C.F., et al. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control 2000, 28(6):465-471.
45. Hartmann B., Benson M., Junger A., et al. Computer keyboard and mouse as a reservoir of pathogens in an intensive care unit. JClin Monit Comput 2004, 18(1):7-12.
46. Curtis L., Cali S., Conroy L., et al. Aspergillus surveillance project at a large tertiary-care hospital. JHosp Infect 2005, 59(3):188-196.
47. Lee L.D., Berkheiser M., Jiang Y., et al. Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy. Infect Control Hosp Epidemiol 2007, 28(9):1066-1070.
48. Hayden M.K., Bonten M.J., Blom D.W., et al. Reduction in acquisition of vancoycinresistant Enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006, 42(11):1552-1560.
49. Pittet D., Sax H., Hugonnet S., et al. Cost implications of successful hand hygiene promotion. Infect Control Hosp Epidemiol 2004, 25(3):264-266.
50. Eldridge N.E., Woods S.S., Bonello R.S., et al. Using the six sigma process to implement the Centers for Disease Control and Prevention Guideline for hand hygiene in 4 intensive care units. JGen Intern Med 2006, 21(Suppl 2):S35-S42.
51. Boyce J.M., Pittet D., Healthcare Infection Control Practices Advisory Committee, Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America, Hand Hygiene Task Force Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002, 23(12 Suppl):S3-S40.
52. Rupp M.E., Fitzgerald T., Puumala S., et al. Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units. Infect Control Hosp Epidemiol 2008, 29(1):8-15.
53. Girou E., Loyeau S., Legrand P., et al. Efficacy of handrubbing with alcohol based solution versus standard handwashing with antiseptic soap: randomized clinical trial. BMJ 2002, 325(7360):362-366.
54. Larson E.L., Aiello A.E., Bastyr J., et al. Assessment of two hand hygiene regimens for intensive care unit personnel. Crit Care Med 2001, 29(5):944-951.
55. Jernigan J.A., Titus M.G., Gröschel D.H., et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996, 143(5):496-504.
56. Haley R.W., Cushion N.B., Tenover F.C., et al. Eradication of endemic methicillinresistant Staphylococcus aureus infections from a neonatal intensive care unit. JInfect Dis 1995, 171(3):614-624.
57. Safdar N., Marx J., Meyer N.A., et al. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. Am J Infect Control 2006, 34(8):476-483.
58. Mangini E., Segal-Maurer S., Burns J., et al. Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2007, 28(11):1261-1266.
59. Rubinovitch B., Pittet D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned?. JHosp Infect 2001, 47(1):9-18.
60. Lucet J.C., Paoletti X., Lolom I., et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005, 31(8):1051-1057.
61. Huang S.S., Yokoe D.S., Hinrichsen V.L., et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin- resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006, 43(8):971-978.
62. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003, 24(5):362-386.
63. Calfee D.P., Giannetta E.T., Durbin L.J., et al. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003, 37(3):326-332.
64. Boyce J.M., Mermel L.A., Zervos M.J., et al. Controlling vancomycin-resistant Enterococci. Infect Control Hosp Epidemiol 1995, 16(11):634-637.
65. Ostrowsky B.E., Trick W.E., Sohn A.H., et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. NEngl J Med 2001, 344(19):1427-1433.
66. Perencevich E.N., Fisman D.N., Lipsitch M., et al. Projected benefits of active surveillance for vancomycin-resistant Enterococci in intensive care units. Clin Infect Dis 2004, 38(8):1108-1115.
67. Kurup A., Chlebicki M.P., Ling M.L., et al. Control of a hospital-wide vancomycinresistant Enterococci outbreak. Am J Infect Control 2008, 36(3):206-211.
68. Mascini E.M., Troelstar A., Beitsma M., et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006, 42(6):739-746.
69. Byers K.E., Anglim A.M., Anneski C.J., et al. Ahospital epidemic of vancomycinresistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001, 22(3):140-147.
70. Karchmer T.B., Durbin L.J., Simonton B.M., et al. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillinresistant Staphylococcus aureus. JHosp Infect 2002, 51(2):126-132.
71. Muto C.A., Giannetta E.T., Durbin L.J., et al. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002, 23(8):429-435.
72. Tenorio A., Badri S., Sahgal N., et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant Enterococcus species by health care workers after patient care. Clin Infect Dis 2001, 32:826-829.
73. Siegel JD, Rhinehart E, Jackson M, etal. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Available at: Accessed January 13, 2009. http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf.
74. Srinivasan A., Song X., Ross T., et al. Aprospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant Enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002, 23(8):424-428.
75. Puzniak L.A., Gillespie K.N., Leet T., et al. Acost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?. Infect Control Hosp Epidemiol 2004, 25(5):418-424.
76. Montecalvo M.A., Jarvis W.R., Uman J., et al. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant Enterococci in an endemic setting. Infect Control Hosp Epidemiol 2001, 22(7):437-442.
77. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillinresistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299(10):1149-1157.
78. Vernon M.O., Hayden M.K., Trick W.E., et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant Enterococci. Arch Intern Med 2006, 166(3):306-312.
79. Bleasdale S.C., Trick W.E., Gonzalez I.M., et al. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007, 167(19):2073-2079.
80. Huang S.S., Septimus E., Kleinman K., et al. Targeted versus universal decolonization to prevent ICU infection. NEngl J Med 2013, 368:2255.
81. Climo M.W., Sepkowitz K.A., Zuccotti G., et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009, 37:1858.
82. Munoz-Price L.S., Hota B., Stemer A., et al. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009, 30:1031.
83. Borer A., Gilad J., Porat N., et al. Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. JHosp Infect 2007, 67:149.
84. O'Horo J.C., Silva G.L., Munoz-Price L.S., et al. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012, 33:257.
85. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388.
86. Safdar N., Dezfulian C., Collard H.R., et al. Clinical and economic consequences of ventilator associated pneumonia: a systematic review. Crit Care Med 2005, 33(10):2184-2193.
87. Rello J., Ollendorf D.A., Oster G., et al. Epidemiology and outcomes of ventilator associated pneumonia in a large US database. Chest 2002, 122(6):2115-2121.
88. Heyland D.K., Cook D.J., Griffith L., et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999, 159:1249-1256.
89. Kappstein I., Schulgen G., Beyer U., et al. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992, 11:504-508.
90. Fagon J.Y., Chastre J., Hance A.J., et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993, 94:281-288.
91. Tablan O.C., Anderson L.J., Besser R., Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention, et al. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004, 53(RR-3):1-36.
92. Celis R., Torres A., Gatell J.M., et al. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 1988, 93:318-324.
93. Torres A., Gatell J.M., Aznar E., et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995, 152:137-141.
94. Kollef M.H. The prevention of ventilator-associated pneumonia. NEngl J Med 1999, 340:627-634.
95. Craven D.E., Steger K.A. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin Respir Infect 1996, 11:32-53.
96. Esteban A., Frutos-Vivar F., Ferguson N.D., et al. Noninvasive positive-pressure ventilation for respiratory failure after extubation. NEngl J Med 2004, 350:2452-2460.
97. Nava S., Ambrosino N., Clini E., et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: a randomized, controlled trial. Ann Intern Med 1998, 128:721-728.
98. Carlucci A., Richard J.C., Wysocki M., et al. Noninvasive versus conventional mechanical ventilation: an epidemiologic survey. Am J Respir Crit Care Med 2001, 163:874-880.
99. Nourdine K., Combes P., Carton M.J., et al. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med 1999, 25:567-573.
100. Keenan S.P. Noninvasive positive pressure ventilation in acute respiratory failure. JAMA 2000, 284:2376-2378.
101. Holzapfel L., Chastang C., Demingeon G., et al. Arandomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator associated pneumonia. Am J Respir Crit Care Med 1999, 159:695-701.
102. Valles J., Artigas A., Rello J., et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995, 122:179-186.
103. Mahul P., Auboyer C., Jospe R., et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med 1992, 18:20-25.
104. Kollef M.H., Skubas N.J., Sundt T.M. Arandomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 1999, 116:1339-1346.
105. Cook D., De Jonghe B., Brochard L., et al. Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials. JAMA 1998, 279:781-787.
106. Rello J., Sonora R., Jubert P., et al. Pneumonia in intubated patients: role of respiratory airway care. Am J Respir Crit Care Med 1996, 154:111-115.
107. Torres A., Serra-Batlles J., Ros E., et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992, 116:540-543.
108. Orozco-Levi M., Torres A., Ferrer M., et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med 1995, 152:1387-1390.
109. Davis K., Johannigman J.A., Campbell R.S., et al. The acute effects of body position strategies and respiratory therapy in paralyzed patients with acute lung injury. Crit Care 2001, 5:81-87.
110. DeRiso A.J., Ladowski J.S., Dillon T.A., et al. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996, 109:1556-1561.
111. Kress J.P., Pohlman A.S., O'Connor M.F., et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. NEngl J Med 2000, 342:1471-1477.
112. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 2000, 132:391-402. [Erratum appears in Ann Intern Med 2000;133:395].
113. Mermel L.A. Prevention of central venous catheter-related infections: what works other than impregnated or coated catheters?. JHosp Infect 2007, 65:30-33.
114. Centers for Disease Control and Prevention (CDC) Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011, 60:243.
115. Fagan R.P., Edwards J.R., Park B.J., et al. Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990-2010. Infect Control Hosp Epidemiol 2013, 34:893.
116. Scott RD. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. Available at: Accessed on January 28, 2014. http://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf.
117. Tokars J.I., Cookson S.T., McArthur M.A., et al. Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med 1999, 131:340.
118. Reunes S., Rombaut V., Vogelaers D., et al. Risk factors and mortality for nosocomial bloodstream infections in elderly patients. Eur J Intern Med 2011, 22:e39.
119. Mermel L.A., McCormick R.D., Springman S.R., et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991, 91(3B):197S-205S.
120. Richet H., Hubert B., Nitemberg G., et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. JClin Microbiol 1990, 28:2520.
121. Merrer J., De Jonghe B., Golliot F., et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001, 286:700.
122. Ronco C. The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis. Crit Care 2005, 9:631.
123. Pessa M.E., Howard R.J. Complications of Hickman-Broviac catheters. Surg Gynecol Obstet 1985, 161:257.
124. Darbyshire P.J., Weightman N.C., Speller D.C. Problems associated with indwelling central venous catheters. Arch Dis Child 1985, 60:129.
125. Groeger J.S., Lucas A.B., Thaler H.T., et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993, 119:1168.
126. Ross M.N., Haase G.M., Poole M.A., et al. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988, 167:141.
127. Carde P., Cosset-Delaigue M.F., Laplanche A., et al. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 1989, 25:939.
128. Raad I.I., Hohn D.C., Gilbreath B.J., et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994, 15:231-238.
129. Maki D.G. Yes, Virginia, aseptic technique is very important: maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia. Infect Control Hosp Epidemiol 1994, 15:227.
130. Wilcox T.A. Catheter-related bloodstream infections. Semin Intervent Radiol 2009, 26:139.
131. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999, 281:261.
132. Goede M.R., Coopersmith C.M. Catheter-related bloodstream infection. Surg Clin North Am 2009, 89:463-474.
133. Centers for Disease Control and Prevention Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002, 51(RR-16):1-45.
134. Rosenthal V.D., Guzman S., Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005, 33:392-397.
135. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004, 32:2014-2020.
136. Hu K.K., Lipsky B.A., Veenstra D.L., et al. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control 2004, 32:142-146.
137. Young E.M., Commiskey M.L., Wilson S.J. Translating evidence into practice to prevent central-venous catheter-associated bloodstream infections: a systems based intervention. Am J Infect Control 2006, 34:503-506.
138. Maki D.G., Ringer M., Alvarado C.J. Prospective randomized trial of povidoneiodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991, 338:339-343.
139. Humar A., Ostromecki A., Direnfeld J., et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000, 31:1001-1007.
140. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-side care: a meta-analysis. Ann Intern Med 2002, 136:792-801.
141. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., et al. Vascular catheter site care; the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 2003, 37:764-771.
142. Valles J., Fernandez I., Alcaraz D., et al. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients. Infect Control Hosp Epidemiol 2008, 29:847-853.
143. Goetz A.M., Wagener M.M., Muder R.R. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998, 19:842-845.
144. Hamilton H.C., Foxcroft D. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database Syst Rev 2007, (3). [review], CD004084. 10.1002/14651858.pub2:CD004084.
145. Hind D., Calvert N., McWiliams R., et al. Ultrasonic location devices for central venous cannulation: meta-analysis. BMJ 2003, 327:361.
146. Venkataraman S.T., Thompson A.E. Femoral vascular catheterization in critically ill infants and children. Clin Pediatr (Phila) 1997, 36:311-319.
147. Sheridan R.L., Weber J.M. Mechanical and infectious complications of central venous cannulation in children: lessons learned from a 10-year experience placing more than 1000 catheters. JBurn Care Res 2006, 27:713-718.
148. Stenzel J.P., Green T.P., Fuhrman R.P., et al. Percutaneous central venous catheterization in a pediatric intensive care unit: a survival analysis of complications. Crit Care Med 1989, 17:984-988.
149. Randolph A.G., Cook D.J., Gonzales C.A., et al. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 1998, 26:1452-1457.
150. Salzman M.B., Isenberg H.D., Rubin L.G. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. JClin Microbiol 1993, 31:475-479.
151. Luebke M.A., Arduino M.J., Duda D.L., et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control 1998, 26:437-441.
152. Casey A.L., Worthington T., Lambert P.A., et al. Arandomized, prospective clinical trial to access the potential infection risk associated with the PosiFlow needleless connector. JHosp Infect 2003, 54:288-293.
153. Lederle F.A., Parenti C.M., Berskow L.C., et al. The idle intravenous catheter. Ann Intern Med 1992, 116:737-738.
154. Parenti C.M., Lederle F.A., Impola C.L., et al. Reduction of unnecessary intravenous catheter use. Arch Intern Med 1994, 154:1829-1832.
155. Gillies D., Walen N.M., Morrison A.L., et al. Optimal timing for intravenous administration set replacements. Cochrane Database Syst Rev 2005, (4). CD003588. 10.1002/14651858.pub2:CD003588.
156. Zakrzewska-Bode A., Muytjens H.L., Liem K.D., et al. Mupirocin resistance in coagulase- negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. JHosp Infect 1995, 31:189-193.
157. Flowers R.H., Schwenzer K.J., Kopel R.F., et al. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 1989, 10:878-883.
158. van de Wetering M.D., van Woensel J.B. Prophylactic antibiotics for preventing early central venous catheter gram positive infections among oncology patients. Cochrane Database Syst Rev 2007, (24). CD003295.
159. Bartlett J.G., Chang T.W., Gurwith M., et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. NEngl J Med 1978, 298:531-534.
160. Barbut F., Corthier G., Charpak Y., et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med 1996, 156:1449-1454.
161. Wiesen P., Van Gossum A., Preiser J.C. Diarrhoea in the critically ill. Curr Opin Crit Care 2006, 12:149-154.
162. Zilberberg M.D. Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis 2009, 15:122-124.
163. Labbe A.C., Poirier L., Maccannell D., et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 2008, 52:3180-3187.
164. Loo V.G., Poirier L., Miller M.A., et al. Apredominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. NEngl J Med 2005, 353:2442-2449.
165. Pepin J., Valiquette L., Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005, 173:1037-1042.
166. Bignardi G.E. Risk factors for Clostridium difficile infection. JHosp Infect 1998, 40:1-15.
167. Dubberke E.R., Reske K.A., Yan Y., et al. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007, 45:1543-1549.
168. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
169. Johnson S., Samore M.H., Farrow K.A., et al. Epidemics of diarrhea caused by clindamycin-resistant strain of Clostridium difficile in four hospitals. NEngl J Med 1999, 341(22):1645-1651.
170. Gerding D.M., Muto C.A., Owens R.C. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl 1):S43-S49.
171. Valiquette L., Cossette B., Garant M.P., et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007, 45(Suppl 2):S112-S121.
172. Chenoweth C.E., Saint S. Urinary tract infections. Infect Dis Clin North Am 2011, 25:103-117.
173. Nicolle L.E. Urinary catheter-associated infections. Infect Dis Clin North Am 2012, 26:13-27.
174. Shuman K., Chenoweth C.E. Recognition and prevention of healthcare-associated urinary tract infections in the intensive care unit. Crit Care Med 2010, 38:S373-S379.
175. Platt R., Polk B.F., Murdock B., et al. Mortality associated with nosocomial urinary-tract infection. NEngl J Med 1982, 307:637-642.
176. Burton D.C., Edwards J.R., Srinivasan A., et al. Trends in catheter-associated urinary tract infections in adult intensive care units-United States, 1990-2007. Infect Control Hosp Epidemiol 2011, 32:748-756.
177. Saint S., Meddings J.A., Calfee D., et al. Catheter-associated urinary tract infection and the medicare rule changes. Ann Intern Med 2009, 150:877-884.
178. Umsheid C.A., Mitchell M.D., Doshi J.A., et al. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011, 32:101-114.
179. Rebmann T., Greene L.R. Preventing catheter-associated urinary tract infections: an executive summary of the Association for Professionals in Infection Control and Epidemiol. Am J Infect Control 2010, 38:644-646.
180. Gould C.V., Umscheid C.A., Agarwal R.K., Healthcare Infection Control Practices Advisory Committee (HICPAC), et al. CDC guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010, 31:319-326.
181. Lo E., Nicolle L., Classen D., et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S41-S50.
182. Fakih M.G., Dueweke C., Meisner S., et al. Effect of nurse-led multidisciplinary rounds on reducing the unnecessary use of urinary catheterization in hospitalized patients. Infect Control Hosp Epidemiol 2008, 29:815-819.
183. Saint S., Kaufman S.R., Thompson M., et al. Areminder reduces urinary catheterization in hospitalized patients. Jt Comm J Qual Patient Saf 2005, 31:455-462.
184. Huang W.C., Wann S.R., Lin S.L., et al. Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters. Infect Control Hosp Epidemiol 2004, 25:974-978.
185. Cornia P.B., Amory J.K., Fraser S., et al. Computer-based order entry decreases duration of indwelling urinary catheterization in hospitalized patients. Am J Med 2003, 114:404-407.
186. Meddings J., Rogers M.A., Macy M., et al. Systematic review and metaanalysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis 2010, 51:550-560.
187. Wright M.O., Kharasch M., Beaumont J.L., et al. Reporting catheter-associated urinary tract infections: denominator matters. Infect Control Hosp Epidemiol 2011, 32:635-640.
188. Niel-Weise B.S., van den Broek P.J. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev 2005, (3). CD004203.
189. Stevens E. Bladder ultrasound: avoiding unnecessary catheterizations. Medsurg Nurs 2005, 14:249-253.
190. Saint S., Kaufman S.R., Rogers M.A., et al. Condom versus indwelling urinary catheters: a randomized trial. JAm Geriatr Soc 2006, 54:1055-1061.
191. Saint S., Lipsky B.A., Baker P.D., et al. Urinary catheters: what type do men and their nurses prefer?. JAm Geriatr Soc 1999, 47:1453-1457.
192. Pratt R.J., Pellowe C., Loveday H.P., et al. Guidelines for preventing infections associated with the insertion and management of short term indwelling urethral catheters in acute care. JHosp Infect 2001, 47(Suppl):S39-S46.